Endothelial dysfunction—a major mediator of diabetic vascular disease CM Sena, AM Pereira, R Seiça Biochimica et Biophysica Acta (BBA)-molecular basis of Disease 1832 (12 …, 2013 | 1066 | 2013 |
Asthma costs and social impact C Nunes, AM Pereira, M Morais-Almeida Asthma research and practice 3, 1-11, 2017 | 921 | 2017 |
The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study FR Machado, AB Cavalcanti, FA Bozza, EM Ferreira, FSA Carrara, ... The Lancet infectious diseases 17 (11), 1180-1189, 2017 | 409 | 2017 |
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ... Clinical and translational allergy 6 (1), 47, 2016 | 247 | 2016 |
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 208 | 2021 |
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–a EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement PW Hellings, WJ Fokkens, C Bachert, CA Akdis, T Bieber, I Agache, ... Allergy 72 (9), 1297-1305, 2017 | 200 | 2017 |
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology J Bousquet, PW Hellings, I Agache, F Amat, I Annesi-Maesano, ... Journal of Allergy and Clinical Immunology 143 (3), 864-879, 2019 | 180 | 2019 |
MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ... Clinical and translational allergy 8 (1), 45, 2018 | 175 | 2018 |
Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 173 | 2020 |
Treatment of allergic rhinitis using mobile technology with real‐world data: the MASK observational pilot study J Bousquet, P Devillier, S Arnavielhe, A Bedbrook, G Alexis‐Alexandre, ... Allergy 73 (9), 1763-1774, 2018 | 167 | 2018 |
Physiological changes induced by the quaternary ammonium compound benzyldimethyldodecylammonium chloride on Pseudomonas fluorescens C Ferreira, AM Pereira, MC Pereira, LF Melo, M Simões Journal of Antimicrobial Chemotherapy 66 (5), 1036-1043, 2011 | 167 | 2011 |
Inhaler devices in asthma and COPD–an assessment of inhaler technique and patient preferences P Chorao, AM Pereira, JA Fonseca Respiratory Medicine 108 (7), 968-975, 2014 | 153 | 2014 |
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 148 | 2021 |
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study A Bédard, X Basagana, JM Anto, J Garcia-Aymerich, P Devillier, ... Journal of Allergy and Clinical Immunology 144 (1), 135-143. e6, 2019 | 148 | 2019 |
Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study J Bousquet, DP Caimmi, A Bedbrook, M Bewick, PW Hellings, P Devillier, ... Allergy 72 (6), 857-865, 2017 | 147 | 2017 |
Guidance to 2018 good practice: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma J Bousquet, A Bedbrook, W Czarlewski, GL Onorato, S Arnavielhe, ... Clinical and translational allergy 9 (1), 16, 2019 | 134 | 2019 |
Work productivity in rhinitis using cell phones: the MASK pilot study J Bousquet, M Bewick, S Arnavielhe, E Mathieu‐Dupas, R Murray, ... Allergy 72 (10), 1475-1484, 2017 | 115 | 2017 |
Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control D Caimmi, N Baiz, LK Tanno, P Demoly, S Arnavielhe, R Murray, ... Clinical & Experimental Allergy 47 (12), 1526-1533, 2017 | 107 | 2017 |
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines I Agache, C Rocha, A Pereira, Y Song, P Alonso‐Coello, I Solà, J Beltran, ... Allergy 76 (1), 59-70, 2021 | 102 | 2021 |
Prevalence and classification of rhinitis in preschool children in P ortugal: a nationwide study M Morais‐Almeida, N Santos, AM Pereira, M Branco‐Ferreira, C Nunes, ... Allergy 68 (10), 1278-1288, 2013 | 101 | 2013 |